The citrus bioflavonoids market is poised for significant growth, with projections indicating a valuation of ~US$ 2 billion by the end of 2030. This remarkable expansion is driven by the increasing recognition of citrus bioflavonoids' potential in managing blood sugar levels, controlling blood pressure, and reducing inflammation. Companies in the market are actively engaged in clinical trials...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek